0000899243-20-028931.txt : 20201021
0000899243-20-028931.hdr.sgml : 20201021
20201021210809
ACCESSION NUMBER: 0000899243-20-028931
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201019
FILED AS OF DATE: 20201021
DATE AS OF CHANGE: 20201021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Swisher Daniel N JR
CENTRAL INDEX KEY: 0001323113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 201251466
MAIL ADDRESS:
STREET 1: C/O SUNESIS PHARMACEUTICALS, INC.
STREET 2: 395 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-19
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001323113
Swisher Daniel N JR
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2020-10-19
4
M
0
5000
6.55
A
5000
D
Common Stock
2020-10-19
4
S
0
5000
17.6602
D
0
D
Stock Option (Right to Buy)
6.55
2020-10-19
4
M
0
5000
0.00
D
2025-06-18
Common Stock
5000
55000
D
The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $17.51 to $17.96 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.
Fully exercisable.
/s/ Charles Robb, Attorney-in-Fact for Daniel N. Swisher, Jr.
2020-10-21